Schloissnig, Siegfried https://orcid.org/0000-0003-4574-8330
Pani, Samarendra https://orcid.org/0009-0002-2037-2533
Ebler, Jana
Hain, Carsten https://orcid.org/0000-0002-6206-9906
Tsapalou, Vasiliki
Söylev, Arda
Hüther, Patrick https://orcid.org/0000-0003-3315-2484
Ashraf, Hufsah
Prodanov, Timofey https://orcid.org/0000-0001-7469-6651
Asparuhova, Mila https://orcid.org/0000-0002-8597-4116
Magalhães, Hugo https://orcid.org/0000-0002-6807-1548
Höps, Wolfram
Sotelo-Fonseca, Jesus Emiliano
Fitzgerald, Tomas https://orcid.org/0000-0002-2370-8496
Santana-Garcia, Walter
Moreira-Pinhal, Ricardo https://orcid.org/0000-0002-2744-4790
Hunt, Sarah https://orcid.org/0000-0002-8350-1235
Pérez-Llanos, Francy J.
Wollenweber, Tassilo Erik https://orcid.org/0000-0001-7953-9903
Sivalingam, Sugirthan
Wieczorek, Dagmar https://orcid.org/0000-0003-2812-6492
Cáceres, Mario https://orcid.org/0000-0002-7736-3251
Gilissen, Christian https://orcid.org/0000-0003-1693-9699
Birney, Ewan https://orcid.org/0000-0001-8314-8497
Ding, Zhihao
Jensen, Jan Nygaard
Podduturi, Nikhil
Stutzki, Jan
Rodriguez-Martin, Bernardo
Rausch, Tobias https://orcid.org/0000-0001-5773-5620
Marschall, Tobias https://orcid.org/0000-0002-9376-1030
Korbel, Jan O. https://orcid.org/0000-0002-2798-3794
Article History
Received: 22 April 2024
Accepted: 16 June 2025
First Online: 23 July 2025
Competing interests
: Z.D., J.N.J. and N.P. are employees of Boehringer Ingelheim Pharma GmbH & Co. KG. J.S. is an employee of BI X GmbH. E.B. is a consultant for and shareholder of Oxford Nanopore Technologies. The other authors declare no competing interests.